PreprintAll rights reservedbioRxiv
Identification of Novel Inhibitors of JEV RdRp as Potent Antiviral Drugs: Targeting NS5-NS3 Protein Interaction
- 1AcSIR, CSIR-Central Drug Research Institute
Related
- Repositioning antiviral phytoconstituents as broad-spectrum inhibitors of influenza A neuraminidase and human metapneumovirus fusion protein
- High-throughput screening to identify inhibitors of the MTB CARD•RNA polymerase protein-protein interaction
- Sigma‐1 Receptor‐Targeting Compounds Show Antiviral Activity Across Multiple Coronavirus Models
- Antiviral activity of HSP90 inhibitors against Mumps virus and related paramyxoviruses
- Seesaw configuration of the ODC-OAZ1-AZIN1 axis governs sensitivity to polyamine-targeting inhibitors of breast cancer cells
BibTeX
@misc{mishra2026identification,
title = {{Identification of Novel Inhibitors of JEV RdRp as Potent Antiviral Drugs: Targeting NS5-NS3 Protein Interaction}},
author = {P. Mishra and S. Mishra and G. Srivastava and K. Archana and M. I. Siddiqi and S. Haldar and R. K. Tripathi},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.23.753689},
url = {https://www.biorxiv.org/content/10.64898/2026.09.23.753689v1},
}
RIS
TY - UNPB
TI - Identification of Novel Inhibitors of JEV RdRp as Potent Antiviral Drugs: Targeting NS5-NS3 Protein Interaction
AU - P. Mishra
AU - S. Mishra
AU - G. Srivastava
AU - K. Archana
AU - M. I. Siddiqi
AU - S. Haldar
AU - R. K. Tripathi
PY - 2026
DA - 2026/09/23
PB - bioRxiv
DO - 10.64898/2026.09.23.753689
UR - https://www.biorxiv.org/content/10.64898/2026.09.23.753689v1
ER -